BASF

Formulation of poorly soluble APIs remains one of the most persistent challenges in modern pharmaceutical development. With a growing number...

Abstract Cannabidiol (CBD) exhibits poor oral bioavailability (approximately 6%) due to low solubility and excessive first-pass metabolism, limiting its therapeutic...

Abstract Background: The therapeutic potential of many natural products, including curcumin (CUR), betulinic acid (BA), and oleanolic acid (OA), is limited...

Abstract Transdermal drug delivery offers several advantages over conventional routes. However, its use is limited by the low permeability of...

Abstract The nanocrystalline suspensions (NCS) are aqueous colloidal dispersions susceptible to Ostwald ripening and particle aggregation during processing and storage....

Abstract Dapivirine (DPV) is an antiretroviral drug used for prevention of sexually acquired HIV infection in the form of a...

Focused on your needs – BASF solutions for the pharmaceutical industry BASF produces excipients and active ingredients of outstanding quality...

Abstract Two major challenges for developers of drug-releasing vaginal rings are (i) the formulation and release of hydrophilic water-soluble actives,...

Abstract This study explores the development of a self-nanoemulsifying drug delivery system (SNEDDS) to enhance the biopharmaceutical profile of lornoxicam,...

Abstract Mucopolysaccharidosis type I (MPS-I) is a rare, multisystemic lysosomal storage disease (LSD) caused by mutations in the IDUA gene, which encodes...